FDA actions, court filings, recalls, and scientific studies across every major active tort — AI-aggregated, scored, and routed to the plaintiff attorneys who can act on them first.
📰 Daily intelligence brief
Wednesday, April 15, 2026 · 11:24 AM EDT
★ Verdicts & settlements
Pa. jury awards $78M in latest Roundup NHL verdict. Pennsylvania state court continues as the most plaintiff-friendly venue post-MDL wind-down.
★ MDL momentum
Ozempic MDL 3094 bellwether discovery deadlines set. First trials projected late 2026. Pre-bellwether window remains the lowest-CPL period for GLP-1 intake.
★ Regulatory fuel
EPA finalizes PFOA/PFOS hazardous designation under CERCLA. Expands cleanup liability and personal injury claim universe across 45+ states.
📊 Litigation intelligence dashboard
MDL 3094 (E.D. Pa.) · Gastroparesis
MDL 3140 (N.D. Cal.) · Intracranial meningioma (brain tumor)
State courts (PA, MO active) · Non-Hodgkin lymphoma (NHL)
MDL 2873 (D.S.C.) · Kidney cancer
MDL 2873 (D.S.C.) · Kidney
MDL 2738 (D.N.J.) · Ovarian cancer
MDL 3026 (N.D. Ill.) · Necrotizing enterocolitis (NEC) in premature infants
MDL 2846 (S.D. Ohio) · Mesh failure
EDNC consolidated proceedings · Cancers
MDL 3004 (S.D. Ill.) · Parkinson's disease
💡 TortSignal Picks — opportunities by stage
Strong science · Verdicts building · Window closing
Roundup remains active in state courts despite Bayer's $11B settlement program.
View intel →
PFAS contamination is the largest environmental tort in U.
View intel →
J&J's third bankruptcy attempt (LTL Management) was rejected in 2024.
View intel →
MDL forming · Early-mover advantage
Ozempic and other GLP-1 agonists (Wegovy, Mounjaro, Zepbound) are linked to severe gastroparesis, intestinal obstruction, and gallbladder injuries.
View intel →
March 2024 BMJ study established a 5.
View intel →
Paraquat is a restricted-use herbicide linked to Parkinson's disease in agricultural workers.
View intel →
Novel theory · First-mover advantage extreme
Where signals become clients
Every Tier 1 and Tier 2 signal generates a high-intent lead pipeline. Pick a tort, set your geography and budget, and we route vetted plaintiffs straight to your intake.
Choose any active or emerging signal.
State, injury type, monthly budget.
Screened plaintiffs delivered to your CRM.
Lock territory with Elite tier.